Magellan News

Magellan Update August 2024

From the Chair Magellan Continues to progress its operational and strategic plans. With a focus on a successful laboratory licensing process for the TGA, publication

Read More »

Magellan Update October 2023

GMP LAB CONSTRUCTION COMPLETED Magellan has completed the construction of the GMP laboratory facility, with the emphasis now on balancing and testing systems. The installation

Read More »

Magellan Update April 2023

BUILDERS ON SITE AT NEW LABS. The building process for Magellan’s new laboratories at Braeside has commenced. The development will include two GMP (Good Manufacturing Practice) laboratories.

Read More »

Magellan is pleased to announce the results of our Phase 1/2 allogeneic (donor) stem cell trial. The findings are published in Osteoarthritis and Cartilage Open the open-access journal of Osteoarthritis Research Society International (OARSI)

Australia’s Federal Health Minister announces $7 million grant to Magellan Stem Cells

NOTE: Magellan Stem Cells does not treat patients. For those seeking more information on osteoarthritis treatment, please contact our collaborative clinical research partner, Melbourne Stem Cell Centre Research

For more information please email info@magellanstemcells.com.au or call 03 9270 8080

Investment Enquiry

Download the full Investor Presentation